- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0004627

About Mepfarma India Private Limited
Data last updated:
Mepfarma India Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC034097. Its GSTIN is 06AAICM2315D1ZY (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Vinay Chadha (Managing Director) and Ramandeep Garg.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.18 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹7.86 Lakh (net margin 2.5%) and EBITDA of ₹18.34 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹1.04 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Mepfarma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0004627). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mepfarmaindia.com.
Company details
Recognitions & Rankings of Mepfarma India
Contact details
Mepfarma India Private Limited's registered office is in Chandigarh, Chandigarh. Its website is mepfarmaindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mepfarma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mepfarma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mepfarma India Private Limited, buy the company report.
Financials of Mepfarma India Private Limited
FY 2025 filings availableMepfarma India Private Limited reported revenue of ₹3.18 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 6% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mepfarma India Private Limited, buy the company report.
Board of directors of Mepfarma India Private Limited
Mepfarma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Chadha Also directs: Ultra Biolabs Private Limited, Logimed Pharma Private Limited | Managing Director | 20 Sep 2012 | 14 Years 2 Months | Current |
| Ramandeep Garg | Director | 20 Sep 2012 | 14 Years 2 Months | Current |
Peer comparison
Mepfarma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rachil Remedies Pvt Ltd | ₹3.19 Cr (FY 2025) | -54.0% | Agra, Uttar Pradesh, India | |||
| Mepfarma India Private Limitedthis company | ₹3.18 Cr (FY 2025) | ₹7.86 Lakh | 2.5% | -6.0% | Chandigarh, India | |
| Babuline Pharma Private Limited | ₹3.18 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India | |||
| Biostella Projects (OPC) Private Limited | ₹3.18 Cr (FY 2025) | 426.0% | Karimganj, Assam, India | |||
| Yuzderm Pharmaceuticals Private Limited | ₹3.17 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mepfarma India Private Limited, buy the company report.
Auditor
Mepfarma India Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2023 | 018361N |
Shareholding
The shareholding of Mepfarma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mepfarma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2019 | 100279595 | Others | ₹1.04 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Mepfarma India Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Court case (S) | Filed against the company by Ajanta Pharma Limited | Disposed |
To see the full case history of Mepfarma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Mepfarma India Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 34 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ultra Drugs Private Limited | |||
| NDB Healthcare So-Solan (H.P.) | |||
| C.B.Healthcare-Nalagarh (H.P) | |||
| an individual supplier | |||
| Blessings Healthcare Private Limited |
To see the full MSME payment records of Mepfarma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Mepfarma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICM2315D1ZY | Haryana | Active | 12 Sep 2019 |
To see the full GST registrations and return filing status of Mepfarma India Private Limited, buy the company report.
Recent activity
Mepfarma India Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Vinay Chadha ceased to be Director on 01 Apr 2013.
Frequently asked questions
Mepfarma India is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2012 (14+ years old) and is registered under CIN U24232CH2012PTC034097.
Mepfarma India has 2 current directors:
- Vinay Chadha - Managing Director
- Ramandeep Garg - Director
The latest financial statements of Mepfarma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mepfarma India is 06AAICM2315D1ZY, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Mepfarma India is U24232CH2012PTC034097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mepfarma India has 2 court cases on record: 2 filed against it. 1 is pending.
Mepfarma India was incorporated on 20 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Mepfarma India by revenue are Rachil Remedies Pvt Ltd, Babuline Pharma Private Limited, Biostella Projects (OPC) Private Limited, Yuzderm Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Vinay Chadha ceased to be Director on 01 Apr 2013. Ramandeep Garg was appointed as Director on 20 Sep 2012. Vinay Chadha was appointed as Managing Director on 20 Sep 2012.
Yes, Mepfarma India is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0004627).
Mepfarma India has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 34 overdue payments to 8 micro and small suppliers. The latest return was filed on 23 May 2019.
Mepfarma India can be reached through the website mepfarmaindia.com. Its registered office is in Chandigarh, India.

